XENPOZYME
XENPOZYME
Approved
DIN Number
02545713
Drug Class
Human
Market Date
N/A
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02545713
AIG Number0165763001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB25 OLIPUDASE ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OLIPUDASE ALFAActive
Strength: 4 MG / VIAL
Monograph: OLIPUDASE ALFA